Dr. Toshitaka Hoppo, MD, PhD

Dr. Hoppo practices at Bioscrip Infusion Services in Morris Plains, New Jersey.

Dr. Hoppo's NPI, 1154589885, was assigned on May 29, 2008. Dr. Hoppo holds New Jersey license 25MA12025400.

Dr. Hoppo's primary practice is Bioscrip Infusion Services, at 102 The American Rd, Morris Plains, NJ 07950 in Morris County. The practice phone is (800) 552-3462.

Dr. Hoppo's primary practice is Bioscrip Infusion Services in Morris Plains, New Jersey. Dr. Hoppo is also affiliated with Robert Wood Johnson University Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Hoppo to 2 more group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hoppo practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Hoppo's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Hoppo's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 13 Medicare services from Dr. Hoppo across 1 procedure code in 2024, all of them office visits, for 33 Medicare patients. Medicare paid $2,581 for them. Every service was in an office.

CMS counts 33 Medicare patients who saw Dr. Hoppo in 2024. The largest group is 75 to 84, with 15 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hoppo's median patient age at 68, with 64% women.

In 2024, Dr. Hoppo wrote 50 Medicare Part D claims for 23 patients. 86% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $360 in total drug cost. In 2023, CMS named 351 claims across 10 drugs.

Dr. Hoppo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hoppo as offering telehealth. CMS counts 82 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Hoppo, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 53 papers to Dr. Hoppo, published from 2010 to 2023. 2020 was the busiest year, with 5. The most frequent topics are Gastroesophageal Reflux, Esophageal Neoplasms and Electric Impedance. Dr. Hoppo has published most often in Surg Endosc. Dr. Hoppo's most frequent co-authors are Yoshihiro Komatsu, MD, Shahin Ayazi, MD and Thomas Leigh Carroll, MD.

Dmand AI links Dr. Hoppo to 2 clinical trials. Conditions studied include Barrett Esophagus, Gastroesophageal Reflux and Esophageal Motility Disorders.

CMS Open Payments shows 242 general payments to Dr. Hoppo from 19 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 73% of the total. Medical Device Business Services, Inc. paid the most, $48,056.